KRONİK BÖBREK YETMEZLİĞİ OLAN HASTALARDA MENOMETRORAJİ TEDAVİSİ İÇİN LEVONORGESTREL SALAN İNTRAUTERİN ARAÇ UYGULANMASI OLGU SUNUMU
Öz
Anemi, kronik böbrek yetmezliği olan hastalarda en önde gelen problemlerden birisidir. Menometroraji, reprodüktif yaşta kronik böbrek yetmezliği olan kadınlarda sık görülür ve bu durum anemiyi arttırmaktadır. Olgumuza düzensiz kanamalarını azaltmak amacı ile Levonorgestrel salan intrauterin araç uygulandı. 6 ayın sonunda kanamaları azalan hastada anemi için aldığı tedavi değişmediği halde, demir kaybı azaltılarak demir tedavisinin anemiyi efektif olarak düzelttiği gözlendi
Anahtar Kelimeler
Kaynakça
- Brenner BM, Lazarus JM. Choronic Renal Failure: Harrison’s Principles of Medicine, 12 th edition 1991; 1: 1151-56.
- Rabelink TJ, Zwagingo JJ, Koomans HA, Sexma JJ. Thrombosis and hemostasis in renal disease. Kidney İnternational 1994; 46: 287-296.
- Saulo K. Chronic Renal Failure: Management, the Lancet 1991; 338: 423-427.
- Steward C, Davidson AM, Grunfeld JP, Kerr P, Ritz E. The Patient with Chronic Renal Failure: Section 9 Oxford Textbook of Clinical. Nephrology, Oxford Medical Publications 1992; s: 1147-1396.
- Kawashimo R, Douchi T, Oki T, Yashinago M, Nagato Y. Menstrual disorders in patients undergoing chronic hemodialysis. J Obstet Gynaecol Res 1998; 24: 367-373.
- Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74-86.
LEVONORGESTREL RELEASING INTRAUTERİNE DEVICE FOR THE TREATMENT OF DISFUNCTIONAL UTERINE BLEEDING IN PATIENTS WITH CHRONIC RENAL FAILURE A CASE REPORT
Öz
Anemia is one of the most important problem in patients with chronic renal failure. In the reproductive years, menometrorrhagia is frequently seen in women who have with chronic renal failure and this aggravates the anemia. Levonorgestrel releasing intrauterine device was inserted to our patient to decrease the irregular uterine bleeding. At the end of six months, eventhough the treatment for anemia altered, with the reduction of iron loss, the anemia was effectively corrected
Anahtar Kelimeler
Menometrorrhagia Levonorgestrel releasing intrauterine device
Kaynakça
- Brenner BM, Lazarus JM. Choronic Renal Failure: Harrison’s Principles of Medicine, 12 th edition 1991; 1: 1151-56.
- Rabelink TJ, Zwagingo JJ, Koomans HA, Sexma JJ. Thrombosis and hemostasis in renal disease. Kidney İnternational 1994; 46: 287-296.
- Saulo K. Chronic Renal Failure: Management, the Lancet 1991; 338: 423-427.
- Steward C, Davidson AM, Grunfeld JP, Kerr P, Ritz E. The Patient with Chronic Renal Failure: Section 9 Oxford Textbook of Clinical. Nephrology, Oxford Medical Publications 1992; s: 1147-1396.
- Kawashimo R, Douchi T, Oki T, Yashinago M, Nagato Y. Menstrual disorders in patients undergoing chronic hemodialysis. J Obstet Gynaecol Res 1998; 24: 367-373.
- Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74-86.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Research Article |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Aralık 2003 |
| Yayımlandığı Sayı | Yıl 2003 Cilt: 9 Sayı: 4 |